Kevin Morgan
#179,131
Most Influential Person Now
Researcher ORCID: 0000-0002-8217-2396
Kevin Morgan's AcademicInfluence.com Rankings
Kevin Morganengineering Degrees
Engineering
#8306
World Rank
#9829
Historical Rank
Electrical Engineering
#2598
World Rank
#2727
Historical Rank
Kevin Morgancomputer-science Degrees
Computer Science
#11224
World Rank
#11867
Historical Rank
Computational Linguistics
#2832
World Rank
#2865
Historical Rank
Machine Learning
#5134
World Rank
#5199
Historical Rank
Artificial Intelligence
#5541
World Rank
#5619
Historical Rank
Download Badge
Engineering Computer Science
Kevin Morgan's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Kevin Morgan Influential?
(Suggest an Edit or Addition)Kevin Morgan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease (2013) (3484)
- TREM2 variants in Alzheimer's disease. (2013) (2173)
- Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease (2011) (1701)
- Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease (2009) (1644)
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes (2009) (1441)
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2013) (1388)
- Analysis of shared heritability in common disorders of the brain (2016) (1385)
- Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease (2014) (1230)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease (2010) (587)
- Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease (2013) (418)
- Common polygenic variation enhances risk prediction for Alzheimer's disease. (2015) (316)
- A NOVEL ALZHEIMER DISEASE LOCUS LOCATED NEAR THE GENE ENCODING TAU PROTEIN (2015) (246)
- New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) (246)
- Replication of CLU, CR1, and PICALM associations with alzheimer disease. (2010) (221)
- Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. (2003) (205)
- Serpins: structure, function and molecular evolution. (2003) (195)
- Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies (2014) (185)
- Convergent genetic and expression data implicate immunity in Alzheimer's disease (2014) (172)
- Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study (2018) (163)
- TREM2 Variants in Alz hei mer's Disease (2012) (118)
- The three new pathways leading to Alzheimer's disease (2011) (118)
- Missense variant in TREML2 protects against Alzheimer's disease (2014) (115)
- Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes (2013) (113)
- A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD. (2000) (110)
- SERPINA3 (aka alpha-1-antichymotrypsin). (2007) (108)
- Gene regulation of the serine proteinase inhibitors α1-antitrypsin and α1-antichymotrypsin (2001) (105)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
- Kinetic Abnormalities of the Red Blood Cell Sodium-Proton Exchange in Hypertensive Patients (1991) (98)
- Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. (1997) (95)
- Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism. (2005) (87)
- Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2021) (85)
- Association of MMP - 12 polymorphisms with severe and very severe COPD: A case control study of MMPs - 1, 9 and 12 in a European population (2010) (81)
- Genetic Differences in Lithium‐Sodium Exchange and Regulation of the Sodium‐Hydrogen Exchanger in Essential Hypertension (1988) (75)
- Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases (2016) (74)
- Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex (2020) (70)
- Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study (2011) (66)
- Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions. (2011) (66)
- Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. (2002) (64)
- Review: The genetics of Alzheimer's disease; putting flesh on the bones (2014) (64)
- Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2009) (64)
- New insights on the genetic etiology of Alzheimer’s and related dementia (2020) (64)
- Investigation of 15 of the top candidate genes for late-onset Alzheimer’s disease (2010) (63)
- A polymorphism of the alpha1‐antitrypsin gene represents a risk factor for liver disease (2007) (62)
- The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. (2012) (61)
- The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project (2010) (58)
- Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease (2014) (58)
- Erythrocyte sodium-potassium-ATPase and sodium transport in obesity. (1981) (58)
- Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project (2012) (58)
- Characterization and partial purification of the sodium-potassium-ATPase inhibitor released from cultured rat hypothalamic cells. (1985) (57)
- Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS) (2012) (57)
- Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease (1999) (56)
- Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease (2010) (56)
- Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease. (2007) (55)
- Shared genetic contribution to ischemic stroke and Alzheimer's disease (2016) (55)
- Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease (2009) (54)
- Alzheimer’s disease polygenic risk score as a predictor of conversion from mild-cognitive impairment (2019) (53)
- Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid. (2012) (51)
- Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk (2019) (51)
- Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. (2006) (48)
- A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression (2016) (47)
- The role of IREB2 and transforming growth factor beta-1 genetic variants in COPD: a replication case-control study (2011) (46)
- Mutation in an alpha1-antitrypsin enhancer results in an interleukin-6 deficient acute-phase response due to loss of cooperativity between transcription factors. (1997) (46)
- A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene (2021) (45)
- Cyclic adenosine monophosphate-stimulated transport of amino acids in kidney cortex. (1972) (45)
- A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease (2018) (45)
- ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease (2014) (44)
- A meta-analysis of epigenome-wide association studies in Alzheimer’s disease highlights novel differentially methylated loci across cortex (2020) (44)
- A multi-center study of ACE and the risk of late-onset Alzheimer's disease. (2011) (42)
- An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis (2001) (41)
- Whole‐exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer's disease (2018) (39)
- A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer’s disease (2005) (39)
- ABCA7 p.G215S as potential protective factor for Alzheimer's disease (2016) (38)
- Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD (2008) (38)
- ABCA7 p.G215S as potential protective factor for Alzheimer's disease (2016) (38)
- Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing (2018) (36)
- Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease☆ (2014) (35)
- Regulation of the serine proteinase inhibitor (SERPIN) gene alpha 1-antitrypsin: a paradigm for other SERPINs. (1997) (34)
- Genetic risk factors in Alzheimer's disease. (1998) (34)
- The SERPINE2 gene and chronic obstructive pulmonary disease. (2006) (34)
- Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease (2010) (34)
- The sex-specific associations of the aromatase gene with Alzheimer’s disease and its interaction with IL10 in the Epistasis Project (2013) (34)
- Independent mutations in the flanking sequence of the alpha-1-antitrypsin gene are associated with chronic obstructive airways disease. (1990) (33)
- Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease (2006) (31)
- Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3 (2018) (31)
- Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3 (2018) (31)
- Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease (2013) (29)
- Point mutation in a 3' flanking sequence of the alpha-1-antitrypsin gene associated with chronic respiratory disease occurs in a regulatory sequence. (1993) (29)
- The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration (2007) (28)
- Microsatellite polymorphism of the α1-antichymotrypsin gene locus associated with sporadic Alzheimer’s disease (1996) (28)
- Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease (2018) (28)
- Polymorphism in the alpha1-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations (2001) (28)
- Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer’s Disease (2016) (27)
- Oncostatin M induced alpha1-antitrypsin (AAT) gene expression in Hep G2 cells is mediated by a 3' enhancer. (2002) (27)
- HLA class I, II & III genes in confirmed late-onset Alzheimer’s disease (2001) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Heritability and genetic variance of dementia with Lewy bodies (2018) (25)
- Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies (2020) (25)
- Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer’s disease (2018) (24)
- Interactions between PPAR-α and inflammation-related cytokine genes on the development of Alzheimer's disease, observed by the Epistasis Project. (2012) (23)
- Rationalising the role of Keratin 9 as a biomarker for Alzheimer’s disease (2016) (22)
- Dopaminergic Medication Effects on the Speech of Individuals with Parkinson's Disease (2009) (22)
- Mutation analysis of sporadic early-onset Alzheimer's disease using the NeuroX array (2017) (21)
- Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer’s disease (2018) (20)
- Erythrocyte sodium-potassium-ATPase and obesity. (1982) (19)
- Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid. (2014) (19)
- Interaction of insulin and PPAR-α genes in Alzheimer’s disease: the Epistasis Project (2012) (19)
- Haplotypes of the alpha‐1 antitrypsin gene in healthy controls and Z deficiency patients (2004) (18)
- PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients (2009) (18)
- Genetic variability in response to Aβ deposition influences Alzheimer’s risk (2018) (18)
- No evidence that extended tracts of homozygosity are associated with Alzheimer's disease (2011) (18)
- Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank (2021) (18)
- Analysis of Genome-Wide Association Study (GWAS) data looking for replicating signals in Alzheimer's disease (AD). (2010) (18)
- Evaluating pathogenic dementia variants in posterior cortical atrophy (2016) (17)
- Linking Protective GAB2 Variants, Increased Cortical GAB2 Expression and Decreased Alzheimer’s Disease Pathology (2013) (16)
- A comprehensive screening of copy number variability in dementia with Lewy bodies (2019) (16)
- The characterization of a mutation of the 3‘ flanking sequence of the α1‐antitrypsin gene commonly associated with chronic obstructive airways disease (1992) (16)
- Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease (2016) (16)
- Genetic Variants in Alzheimer's Disease (2013) (15)
- A comprehensive assessment of benign genetic variability for neurodegenerative disorders (2018) (15)
- Missense variant in TREML 2 protects against Alzheimer ’ s Disease (2013) (15)
- Methylation Profiling RIN3 and MEF2C Identifies Epigenetic Marks Associated with Sporadic Early Onset Alzheimer’s Disease (2017) (15)
- Regulation of the alpha 1-antitrypsin gene and a disease-associated mutation in a related enhancer sequence. (1994) (14)
- Erythrocyte sodium pump activity in human obesity. (1984) (13)
- Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies (2017) (13)
- Psychological stress, cognitive decline and the development of dementia in amnestic mild cognitive impairment (2020) (13)
- Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease. (1990) (12)
- Replication of EPHA 1 and CD 33 associations with late-onset Alzheimer ’ s disease : a multi-centre case-control study (2011) (12)
- Greater frequency of K-ras Val-12 mutation in colorectal cancer as detected with sensitive methods. (1996) (12)
- Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD (2007) (12)
- Association of improved pulmonary phenotype in irish cystic fibrosis patients with a 3′ enhancer polymorphism in alpha‐1‐antitrypsin (2006) (12)
- Calcium retention and increased vascular reactivity caused by a hypothalamic sodium transport inhibitor. (1988) (12)
- A SNP in the ACT gene associated with astrocytosis and rapid cognitive decline in AD (2008) (12)
- The Epistasis Project: A Multi-Cohort Study of the Effects of BDNF, DBH, and SORT1 Epistasis on Alzheimer's Disease Risk. (2019) (11)
- Cognitive phenotypes in Alzheimer's disease and genetic variants in ACE and IDE (2012) (11)
- Inhibitin: a specific inhibitor of sodium/sodium exchange in erythrocytes. (1986) (11)
- Na+/H+ exchange is increased in sickle cell anemia and young normal red cells (1990) (11)
- Effects of Alzheimer's peptide and α1-antichymotrypsin on astrocyte gene expression (2007) (11)
- A Fluorescence Resonance Energy Transfer Assay For Monitoring α- Synclein Aggregation in a Caenorhabditis Elegans Model For Parkinson's Disease. (2015) (11)
- Release of an active sodium transport inhibitor (ASTI) from rat hypothalamic cells in culture. (1984) (11)
- Allele-specific overexpression in astrocytes of an Alzheimer's disease associated alpha-1-antichymotrypsin promoter polymorphism. (2004) (10)
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (vol 41, pg 1088, 2009) (2013) (10)
- Using Fisher's method with PLINK 'LD clumped' output to compare SNP effects across Genome-wide Association Study (GWAS) datasets. (2011) (10)
- Isolation of a sodium transport inhibitory factor, inhibitin, from cultured leukemic promyelocytes. (1984) (9)
- Investigating statistical epistasis in complex disorders. (2011) (9)
- DNA methylation signatures of Alzheimer’s disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types (2022) (9)
- Problems and pitfalls in the isolation of an endogenous Na+, K+-ATPase inhibitor. (1987) (9)
- Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank. (2020) (8)
- Sarcoidosis and MIF gene polymorphism: a case–control study in an Irish population (2006) (8)
- Using In silico LD clumping and meta-analysis of genome-wide datasets as a complementary tool to investigate and validate new candidate biomarkers in Alzheimer's disease. (2010) (8)
- Interactions of external and internal H+ and Na+ with Na+/Na+ and Na+/H+ exchange of rabbit red cells: Evidence for a common pathway (1990) (8)
- Observations of extensive gene expression differences in the cerebellum and potential relevance to Alzheimer’s disease (2018) (8)
- Release of a sodium transport inhibitor (inhibitin) from cultured human cancer cells. (1986) (8)
- Microsatellite polymorphism of the alpha 1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease. (1997) (7)
- Genotyping of the Alzheimer's Disease Genome-Wide Association Study Index Single Nucleotide Polymorphisms in the Brains for Dementia Research Cohort. (2018) (7)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
- Genetic variants in glutamate-, Aβ−, and tau-related pathways determine polygenic risk for Alzheimer's disease (2020) (7)
- as potential protective factor for Alzheimer’s disease (2016) (7)
- Cryptic Haplotypes of SERPINA 1 Confer Susceptibility to Chronic Obstructive Pulmonary Disease (2005) (7)
- Reverse engineering of Alzheimer's disease based on biomarker pathways analysis (2014) (7)
- The alpha-1-antitrypsin gene promoter in human A549 lung derived cells, and a novel transcription initiation site. (2009) (6)
- Commentary on Functional analysis of APOE Locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE (2011) (6)
- Next generation sequencing of CLU, PICALM and CR1: pitfalls and potential solutions. (2012) (6)
- Transforming growth factor beta1 regulates angiotensin II type I receptor gene expression in the extravillous trophoblast cell line SGHPL-4. (2005) (6)
- Genetic risk for Alzheimer’s disease influences neuropathology via multiple biological pathways (2020) (5)
- DEEP SEQUENCING ALZHEIMER'S DISEASE ASSOCIATED GENES, CLU, PICALM, CR1, ABCA7, BIN1, MS4A, CD2AP, EPHA1, AND CD33 IDENTIFIES POTENTIAL FUNCTIONAL SNPS (2014) (5)
- Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease (2022) (5)
- Exome sequencing identifies rare damaging variants in the ATP8B4 and ABCA1 genes as novel risk factors for Alzheimer’s Disease (2020) (5)
- Urinary leak following partial nephrectomy: a contemporary review of 975 cases. (2020) (5)
- Genome-wide association study of age at onset of Alzheimer's disease (2009) (4)
- Correction: Alzheimer’s disease polygenic risk score as a predictor of conversion from mild-cognitive impairment (2019) (4)
- Bridging Integrator 1 (BIN1) (2013) (4)
- PROTEINASE INHIBITORS | Antichymotrypsin (2006) (3)
- ATP-Binding Cassette, Subfamily A (ABC1), Member 7 (ABCA7) (2013) (3)
- Multiple Insulin Degrading Enzyme Variants Alter In Vitro Reporter Gene Expression (2011) (3)
- Common polygenic variation can predict risk of Alzheimer ’ s disease (2016) (3)
- A passive sodium transport inhibitory factor (inhibitin) released from leukaemic promyelocytes in culture. (1984) (3)
- A reproducible procedure for measuring sodium transport in cultured human fibroblasts from normal and obese donors. (1985) (3)
- Genome-wide association findings from the brains for dementia research cohort (2021) (3)
- IDENTIFYING POLYMORPHISMS IN THE ALZHEIMER’S RELATED APP GENE USING THE OXFORD NANOPORE MINION SEQUENCER (2016) (2)
- Sodium-potassium-ATPase and obesity. (1984) (2)
- Interaction of inhibitin with the human erythrocyte Na+(Li+)i/Nao+ exchanger. (1989) (2)
- Exome sequencing identifies rare damaging variants in the ATB8B4 and ABCA1 genes as novel risk factors for Alzheimer’s disease (2021) (2)
- Hypothalamic Sodium-Potassium-ATPase Inhibitor Increases Vascular Reactivity (1986) (2)
- Blood type gene locus has no influence on ACE association with Alzheimer's disease (2015) (2)
- Correction: Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease (2011) (2)
- Complement Component (3b/4b) Receptor 1 (CR1) (2013) (2)
- Preincubation superior to strict competition with mismatched oligonucleotides for detecting alpha 1-antitrypsin deficiency. (1994) (2)
- Vasoreactive effects of hypothalamic sodium transport inhibitor. (1988) (2)
- Membrane-Spanning 4-Domains Subfamily A, MS4A Cluster (2013) (2)
- Plasmonic-array-based biosensors for the diagnosis of neurodegenerative diseases (2011) (2)
- Sialic Acid Binding Immunoglobulin-Like Lectin-3 (CD33) (2013) (1)
- Investigating Splicing Variants Uncovered by Next-Generation Sequencing the Alzheimer’s Disease Candidate Genes, CLU, PICALM, CR1, ABCA7, BIN1, the MS4A Locus, CD2AP, EPHA1 and CD33 (2016) (1)
- Serum stimulation of sodium transport in human fibroblasts containing low and high levels of intracellular sodium (2005) (1)
- ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease (2014) (1)
- Leukaemic promyelocytes and normal bone marrow cells release a passive sodium transport modifier (inhibitin). (1985) (1)
- Upregulated expression of FFAR2 and SOC3 genes is associated with gout (2022) (1)
- The Future Role of Biomarkers in Alzheimer’s Disease Diagnostics (2013) (1)
- Effects of evening primrose oil efamol on erythrocyte sodium transport and obesity (1982) (1)
- Identifying Polymorphisms in the Alzheimer's Related APP Gene Usingthe Minion Sequencer (2016) (1)
- Fetal Rat Hypothalamic Cells Release a Sodium Transport Inhibitor, A Proinhibitor, and Atrial Natriuretic Peptide (1986) (1)
- PD35-11 PSA DENSITY PERFORMS BETTER IN CAUCASIAN MEN THAN IN AFRICAN AMERICAN MEN IN PREDICTING PROSTATE CANCER AND SIGNIFICANT CANCER ON PROSTATE BIOPSY (2019) (1)
- Urolithiasis in pregnancy: Advances in imaging modalities and evaluation of current trends in endourological approaches. (2022) (1)
- The sensitivity of competitive hybridisation for the detection of mutant p53 alleles in a background of wild type. (1995) (1)
- Genetic variability associated with OAS1 expression in myeloid cells increases the risk of Alzheimer’s disease and severe COVID-19 outcomes (2021) (1)
- A REGULATORY VARIANT AT THE TREM GENE CLUSTER ASSOCIATES WITH DECREASED ALZHEIMER’S DISEASE RISK AND INCREASED TREML1 AND TREM2 BRAIN GENE EXPRESSION (2016) (0)
- Sodium proton exchange is increased in hb ss red cells rbc age dependence and interindividual differences (1988) (0)
- INVESTIGATING GENETIC VARIATION IN ALZHEIMER’S DISEASE USING WHOLE-EXOME SEQUENCING (2017) (0)
- Na+/K+ ATPase in Human Liver and Skeletal Muscle (1983) (0)
- Specific Inhibition of Erythrocyte Sodium/Sodium Exchange by Inhibitin (1986) (0)
- Cognitive phenotypes in Alzheimer's disease and insulin degrading enzyme gene variants (2010) (0)
- A Comparative Study of Erythrocyte Sodium-Potassium Atpase and Sodium Transport in Obese and thin Normal Subjects (1981) (0)
- Partial Isolation and Characterisation of a Na++K+-Atpase Inhibitor Released from Hypothalamic Cells in Culture (1985) (0)
- Characterization of Na+ transport in normal human fibroblasts and neoplastic H.Ep.2 cells and the role of inhibitin (1988) (0)
- Running Title: Whole-exome sequencing of the BDR cohort: Evidence to support the role of the PILRA gene in Alzheimer’s disease (2017) (0)
- Sodium Transport Measurements in Cultured Human Fibroblasts Originating from Normal and Obese Donors (1986) (0)
- Association of ACE SNPs including covariates age , gender and APOE (2016) (0)
- P2-167 Mass spectrometric techniques for the identification of differentially expressed proteins in Alzheimer’s disease (2006) (0)
- Does Oxytocin Counteract the Inhibitory Activity of the Hypothalamic Sodium Transport Inhibitor (1984) (0)
- Psychological stress, cognitive decline and the development of dementia in amnestic mild cognitive impairment (2020) (0)
- The Effects of Acth4-10 on Na++K+ ATPase Activity (1984) (0)
- Partial Purification of the Hypothalamic Sodium Transport Inhibitor (1984) (0)
- STUDY OF ERYTHROCYTE SODIUM-POTASSIUM ATPASE AND SODIUM-TRANSPORT IN DIABETES-MELLITUS (1981) (0)
- A SNP in the ACT gene is associated with increased astrocytosis and faster cognitive decline in AD (2007) (0)
- Scavenger receptor class B type I genetic variants associated with disease severity in chronic hepatitis C virus infection (2022) (0)
- Effect of hypothalamic (Na++K+) atpase inhibitor on isolated rabbit aortic strips (1986) (0)
- Secretion of a Sodium Transport Inhibitor (Inhibitin) by Cultured Leukaemic Promyelocytes (1983) (0)
- P3-207: Angiotensin-converting enzyme and the risk of late-onset Alzheimer's disease (2008) (0)
- Effect of Weight Reduction on Erythrocyte Sodium Transport in Obesity (1982) (0)
- Explorer Concordant Association of Insulin Degrading Enzyme Gene ( IDE ) Variants with IDE mRNA , A beta , and Alzheimer ' s Disease (2017) (0)
- The Effect of Fetal Calf Serum on the Sodium Efflux Rate Constant in Cultured Human Fibroblasts (1985) (0)
- USING RNA-SEQ TO IDENTIFY RNA EDITING IN CONTROL AND ALZHEIMER’S DISEASE POSTMORTEM BRAIN TISSUE (2018) (0)
- MP26-10 COULD FINGER ASSIGNMENT AT THE ROBOTIC CONSOLE IMPROVE SURGICAL EDUCATION AND ERGONOMICS OR CAUSE ANY ADVERSE EVENTS? A RANDOMIZED PROSPECTIVE BLINDED SIMULATION PILOT STUDY (2023) (0)
- Correction to: Predicting failed access in unstented ureteroscopy (2023) (0)
- Predicting failed access in unstented ureteroscopy (2023) (0)
- Comment on: Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank: Reply. (2021) (0)
- VALIDATION OF THE ESSENTIAL FRAILTY TOOLSET: CAN FRAILTY BE MEASURED IN THE VIRTUAL CLINIC? (2022) (0)
- Are polymorphisms affecting serum urate, renal urate handling and alcohol intake associated with co-morbidities in gout cases? A case–control study using data from the UK Biobank (2022) (0)
- PRELIMINARY ANALYSIS FROM RNA-SEQUENCING DERIVED FROM FIVE BRAIN REGIONS IN BDR SAMPLES (2017) (0)
- STOP-GAIN VARIANT IN MICROGLIA-EXPRESSED GENE GMIP IS ASSOCIATED WITH EARLY-ONSET ALZHEIMER’S DISEASE (2018) (0)
- MAPPING REGULATORY VARIANTS IN THE ALZHEIMER'S DISEASE CANDIDATE GENE ABCA7 (2016) (0)
- Title : Polygenic risk score in post-mortem diagnosed sporadic early onset Alzheimer ’ s disease (2018) (0)
- INHIBITIN RELEASE BY CANCER CELLS The plasma and bully coat were removed by aspiration after the blood had been centrifuged (2006) (0)
- CD2-Associated Protein ( CD2AP ) (2013) (0)
- Genome-wide association analysis of Dementia with Lewy bodies reveals unique genetic architecture (2017) (0)
- O2-06-01: A powerful, genome-wide association scan for susceptibility genes for late-onset Alzheimer's disease (2008) (0)
- P3-244: Insulin degrading enzyme and the risk of late-onset Alzheimer's disease: A large replication study in a European population (2008) (0)
- P4-074 Alpha-1-antichymotrypsin (ACT) gene haplotyping in Alzheimer's disease (AD) (2004) (0)
- CHASING THE CAUSE OF PLASMA APOE DEFICIENCY IN THE LIVERS OF APOEε4 CARRIERS (2017) (0)
- INVESTIGATING SARM1 VARIANTS IN ALZHEIMER’S DISEASE COHORTS (2016) (0)
- Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes (2022) (0)
- Simple and efficient cDNA capture utilising a short gene-specific probe attached to magnetic beads. (1994) (0)
- Genetic analysis of expression and association in Alzheimer's disease (2009) (0)
- An integrated epigenetic‐genetic study of neuropathology in the Brains for Dementia Research cohort (2020) (0)
- Genome-wide association study of Alzheimer's with psychotic symptoms (2009) (0)
- The Genetics of Alzheimer’s Disease: Introduction and Perspective for the Future (2013) (0)
- Novel Rare Variants in Alzheimer’s Disease Candidate Genes Identified Using Next Generation Sequencing (2011) (0)
- Genetic Variants of Matrix Metalloproteinases 1, 9 and 12 in Chronic Obstructive Pulmonary Disease. (2009) (0)
- Targeted bisulfite sequencing analysis of candidate genes associated with Alzheimer’s disease. (2022) (0)
- Investigating the genetic architecture of Dementia with Lewy bodies: a genome-wide association study (2018) (0)
- [P3–107]: WITHDRAWN (2017) (0)
- Differential Epistatic Interactions with Alternative APOE Alleles in Late-Onset Alzheimer’s Disease (2011) (0)
- Investigating psychosis candidate genes in Alzheimer's disease with psychosis using genome-wide association studies (2009) (0)
- Genome-Wide Association Study of Brain Gene Expression Levels (eGWAS) (2011) (0)
- Original Article Interactions between PPAR-α and inflammation-related cytokine genes on the development of Alzheimer's dis- ease, observed by the Epistasis Project (2012) (0)
- CALCULATING POLYGENIC RISK FOR INDIVIDUALS WITH SPORADIC EARLY ONSET ALZHEIMER’S DISEASE (2017) (0)
- Screening Exon 16 and 17 of the Amyloid Precursor Protein Gene in Sporadic Early-Onset Alzheimer’s Disease (sEOAD) (2016) (0)
- Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2023) (0)
- LINKING POLYGENIC RISK SCORES TO ALZHEIMER'S DISEASE GENES (2018) (0)
- Neurox associations with Alzheimer's disease in african americans (2015) (0)
- INVESTIGATING THE ROLE OF CLU, PICALM, AND CR1 IN ALZHEIMER'S DISEASE (2014) (0)
- Original Article Next generation sequencing of CLU, PICALM and CR1: pitfalls and potential solutions (2012) (0)
- ALZHEIMER’S DISEASE (AD) POLYGENIC RISK SCORE (PRS) AS A PREDICTOR OF CONVERSION FROM MILD COGNITIVE IMPAIRMENT (MCI) (2018) (0)
- P3-201: Polymorphisms in four candidate genes for sporadic Alzheimer's disease are associated with altered rate and age of cognitive decline (2008) (0)
- MULTIPLE ABCA7 MISSENSE VARIANTS MINED FROM THE EXOME VARIANT SERVER SHOW INDEPENDENT ASSOCIATION WITH INCREASED OR DECREASED RISK OF LATE-ONSET ALZHEIMER'S DISEASE (LOAD) (2014) (0)
- Kucukkilic, Ezgi and Brookes, Keeley and Barber, Imelda and Guetta-Baranes, Tamar and Morgan, Kevin and Hollox, Edward (2018) Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer’s disease. Human Genetics (2018) (0)
- RPS16 and NOL6 splice region variants are associated with early onset Alzheimer's disease (2020) (0)
- Next generation sequencing of CLU , PICALM and CR 1 : pitfalls and potential solutions (2012) (0)
- P1-182 Identification of protein factors that bind to the promoter of the alpha-1-antichymotrypsin (ACT) gene: implications for Alzheimer's disease (2004) (0)
- Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies (2020) (0)
- Genetic risk for Alzheimer’s disease influences neuropathology and cognition via multiple biological pathways (2020) (0)
- Erythropoietin-Producing Human Hepatocellular Carcinoma ( EphA1 ) (2013) (0)
- Enzyme-Labelled Oligonucleotides for the Detection of α1-Antitrypsin Deficiency: Optimization of Enzyme Activity for Single Point Mutation Detection (1995) (0)
- P4-043 Gene expression profiles of primary human astrocytes exposed to Abeta and ACT/ABETA complexes assessed using a global DNA microarray (2004) (0)
- Assessment of the contribution of common genetic variants associated with Alzheimer’s disease on neuropathological burden and clinical characteristics in the Brains for Dementia Research cohort (2020) (0)
- Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer’s disease (2018) (0)
- P4-101 The influence of polymorphisms in interleukin -1 gene on amyloid and non-amyloid vascular pathologies in Alzheimer’s disease (2006) (0)
- Next generation sequencing of CLU, PICALM and CR1 (2012) (0)
- Observations of extensive gene expression differences in the cerebellum and potential relevance to Alzheimer’s disease (2018) (0)
- Concordant association of functional IDE variant with IDE mRNA, Aß, and Alzheimer's disease (2009) (0)
- Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease (2018) (0)
- Running Title: EPHX1 and GCL variation in COPD (2008) (0)
- AN INTRONIC 6 BASE PAIR DELETION IN APP THAT POTENTIALLY AFFECTS EXON 17 SPLICING (2014) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- Identification of a sex-specific genetic signature in dementia with Lewy bodies: a meta-analysis of genome-wide association studies (2022) (0)
- Replication of LOAD GWAS Associations (2011) (0)
- Transcription termination and DNase I hypersensitive sites in the 3' flanking sequence of the alpha-1-antitrypsin gene. (1992) (0)
- An examination of previously reported Alzheimer candidate genes within a large genome-wide association dataset (2009) (0)
- Polygenic risk score in post-mortem diagnosed sporadic early onset Alzheimer’s disease (2017) (0)
- FETAL HYPOTHALAMIC CELLS IN CULTURE SECRETE - A SODIUM-TRANSPORT INHIBITOR (1983) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Kevin Morgan?
Kevin Morgan is affiliated with the following schools:
